{"disease":{"id":"genetic-diseases","name":"genetic diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03385876","title":"Rapid Whole Genome Sequencing Study","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Rady Pediatric Genomics & Systems Medicine Institute","has_results":false},{"nct_id":"NCT03131427","title":"China Registry for Genetic / Metabolic Liver Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT04157595","title":"Mackenzie's Mission: The Australian Reproductive Carrier Screening Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":18302,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT00001373","title":"Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT03984266","title":"The Pilot Study of High-throughput Sequencing in Neonatal Birth Defects","phase":"","overall_status":"COMPLETED","enrollment_count":3423,"lead_sponsor_name":"Children's Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT06089954","title":"Penn Medicine Biobank Return of Results Program","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":false},{"nct_id":"NCT05721326","title":"Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition","phase":"NA","overall_status":"COMPLETED","enrollment_count":1330,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":false},{"nct_id":"NCT03627767","title":"Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1235,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01694940","title":"North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT06235580","title":"Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Imagine Institute","has_results":false},{"nct_id":"NCT03720470","title":"Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":838,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06260319","title":"Decoding Developmental Disorders in Humams","phase":"","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT03738098","title":"NYCKidSeq: Incorporating Genomics Into Clinical Care of Diverse NYC Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":650,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT05656261","title":"APOL1 Genetic Testing in African Americans","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"St. Louis University","has_results":false},{"nct_id":"NCT05161169","title":"Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants","phase":"NA","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05587439","title":"Investigating Hereditary Risk In Thoracic Cancers (INHERIT)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05876416","title":"Decoding the Genetic Landscape of Skeletal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03179631","title":"Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT05251467","title":"A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF","phase":"","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Nottingham University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT03321604","title":"Kidney Information Network for Disease Research and Education","phase":"","overall_status":"TERMINATED","enrollment_count":338,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03342495","title":"Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04584528","title":"Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":279,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03054428","title":"Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT05290701","title":"Evaluating Prenatal Exome Sequencing Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":235,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT01826487","title":"Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT03560219","title":"Association of Genetic Polymorphisms With Atrial Fibrosis and Thrombogenic Substrate in Patients With Non-valvular Atrial Fibrillation","phase":"","overall_status":"UNKNOWN","enrollment_count":225,"lead_sponsor_name":"Memorial Ankara Hospital","has_results":false},{"nct_id":"NCT02090959","title":"An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":219,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT03211039","title":"Perinatal Precision Medicine","phase":"NA","overall_status":"UNKNOWN","enrollment_count":213,"lead_sponsor_name":"Rady Pediatric Genomics & Systems Medicine Institute","has_results":true},{"nct_id":"NCT02380729","title":"Mutation Exploration in Non-acquired, Genetic Disorders and Its Impact on Health Economy and Life Quality","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT04208529","title":"A Long-term Follow-up Study in Participants Who Received CTX001","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":160,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT05070234","title":"Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Chunxiu Gong","has_results":false},{"nct_id":"NCT04556487","title":"Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)","phase":"","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT01631617","title":"Effects of Treatments on Atopic Dermatitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT06003153","title":"GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":125,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03862950","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03479476","title":"A Trial of Metformin in Individuals With Fragile X Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06955624","title":"Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":95,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT06475651","title":"Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With Prenatal Onset","phase":"","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03655678","title":"A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT04399694","title":"Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06833489","title":"Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT05479981","title":"Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Avidity Biosciences, Inc.","has_results":false},{"nct_id":"NCT05477563","title":"Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT03876301","title":"Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Spark Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03563066","title":"Effect of Benralizumab in Atopic Dermatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"McMaster University","has_results":true},{"nct_id":"NCT03406780","title":"A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Capricor Inc.","has_results":true},{"nct_id":"NCT05356195","title":"Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT05730842","title":"Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Edgewise Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05657860","title":"Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Maimonides Medical Center","has_results":false},{"nct_id":"NCT00359411","title":"Genetic Studies of X-linked Lymphoproliferative Disease","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}